Wedbush Initiates Coverage On Vera Therapeutics with Outperform Rating, Announces Price Target of $32
Wedbush analyst Laura Chico initiates coverage on Vera Therapeutics (NASDAQ:VERA) with a Outperform rating and announces Price Target of $32.